Funding for this research was provided by:
Forskningsrådet om Hälsa, Arbetsliv och Välfärd (2014-01654)
Received: 22 July 2020
Accepted: 19 August 2020
First Online: 7 September 2020
Ethics approval and consent to participate
: The iPARK trial has been approved by the Regional Ethics Review Board in Umea Sweden (DNR:2016–110-31). An information letter about the study will be sent to potential participants. The Informed consent form will be given to the participant when they arrive at the pre-test. The test leader makes sure that the participant has gotten correct information about the study before signing the informed consent form.
: Not applicable.
: The authors report no conflicting interest.